Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Pathogenesis of Non-Zika Congenital Viral Infections.

Boppana SB, Britt WJ, Fowler K, Hutto SC, James SH, Kimberlin DW, Poole C, Ross SA, Whitley RJ.

J Infect Dis. 2017 Dec 16;216(suppl_10):S912-S918. doi: 10.1093/infdis/jix431.

PMID:
29267912
2.

Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.

Xia L, Su R, An Z, Fu TM, Luo W.

Hum Vaccin Immunother. 2018 Feb 1;14(2):292-303. doi: 10.1080/21645515.2017.1391433. Epub 2017 Dec 1.

PMID:
29053403
3.

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Schleiss MR, Permar SR, Plotkin SA.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00268-17. doi: 10.1128/CVI.00268-17. Print 2017 Dec. Review.

4.

Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.

Britt WJ.

J Virol. 2017 Jul 12;91(15). pii: e02392-16. doi: 10.1128/JVI.02392-16. Print 2017 Aug 1. Review.

5.

Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.

Ha S, Li F, Troutman MC, Freed DC, Tang A, Loughney JW, Wang D, Wang IM, Vlasak J, Nickle DC, Rustandi RR, Hamm M, DePhillips PA, Zhang N, McLellan JS, Zhu H, Adler SP, McVoy MA, An Z, Fu TM.

J Virol. 2017 Mar 13;91(7). pii: e02033-16. doi: 10.1128/JVI.02033-16. Print 2017 Apr 1.

6.

Symptomatic congenital cytomegalovirus disease following non-primary maternal infection: a retrospective cohort study.

Hadar E, Dorfman E, Bardin R, Gabbay-Benziv R, Amir J, Pardo J.

BMC Infect Dis. 2017 Jan 5;17(1):31. doi: 10.1186/s12879-016-2161-3.

7.

Cytomegalovirus and paediatric HIV infection.

Slyker JA.

J Virus Erad. 2016 Oct 5;2(4):208-214.

8.

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen.

Bates M, Brantsaeter AB.

J Virus Erad. 2016 Jul 1;2(3):136-42.

9.

Advances in the prevention and treatment of congenital cytomegalovirus infection.

James SH, Kimberlin DW.

Curr Opin Pediatr. 2016 Feb;28(1):81-5. doi: 10.1097/MOP.0000000000000305. Review.

10.

Exploiting viral natural history for vaccine development.

Barry PA.

Med Microbiol Immunol. 2015 Jun;204(3):255-62. doi: 10.1007/s00430-015-0406-1. Epub 2015 Mar 21. Review.

11.

The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

McCormick AL, Mocarski ES.

Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Epub 2014 Dec 29. Review.

12.

A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.

Auerbach MR, Yan D, Vij R, Hongo JA, Nakamura G, Vernes JM, Meng YG, Lein S, Chan P, Ross J, Carano R, Deng R, Lewin-Koh N, Xu M, Feierbach B.

PLoS Pathog. 2014 Apr 10;10(4):e1004060. doi: 10.1371/journal.ppat.1004060. eCollection 2014 Apr.

13.

Using the nonhuman primate model of HCMV to guide vaccine development.

Deere JD, Barry PA.

Viruses. 2014 Mar 27;6(4):1483-501. doi: 10.3390/v6041483. Review.

14.

HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.

Zydek M, Petitt M, Fang-Hoover J, Adler B, Kauvar LM, Pereira L, Tabata T.

Viruses. 2014 Mar 19;6(3):1346-64. doi: 10.3390/v6031346.

15.

Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.

Smith C, Gras S, Brennan RM, Bird NL, Valkenburg SA, Twist KA, Burrows JM, Miles JJ, Chambers D, Bell S, Campbell S, Kedzierska K, Burrows SR, Rossjohn J, Khanna R.

Sci Rep. 2014 Feb 10;4:3993. doi: 10.1038/srep03993.

16.

Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.

Schleiss MR, McAllister S, Armién AG, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Ramaraj T, Crow JA, McVoy MA.

Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448.

17.

Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Duan YL, Ye HQ, Zavala AG, Yang CQ, Miao LF, Fu BS, Seo KS, Davrinche C, Luo MH, Fortunato EA.

J Virol. 2014 Apr;88(7):3861-73. doi: 10.1128/JVI.01166-13. Epub 2014 Jan 22.

18.

Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection.

Dreher AM, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB, Ross SA.

J Pediatr. 2014 Apr;164(4):855-9. doi: 10.1016/j.jpeds.2013.12.007. Epub 2014 Jan 14.

19.

Congenital cytomegalovirus infection: audiologic outcome.

Fowler KB.

Clin Infect Dis. 2013 Dec;57 Suppl 4:S182-4. doi: 10.1093/cid/cit609.

20.

Congenital cytomegalovirus infection: clinical outcome.

Boppana SB, Ross SA, Fowler KB.

Clin Infect Dis. 2013 Dec;57 Suppl 4:S178-81. doi: 10.1093/cid/cit629.

Supplemental Content

Support Center